Meta-analysis of long-chain polyunsaturated fatty acid supplementation of formula and infant cognition.
OBJECTIVE
Infant formula is supplemented with long-chain polyunsaturated fatty acids (LCPUFAs) because they are hypothesized to improve cognition. Several randomized controlled clinical trials have examined the effect of LCPUFA supplementation of infant formula on cognitive development. We conducted this meta-analysis to examine the efficacy of LCPUFA supplementation of infant formula on early cognitive development.


METHODS
Two authors searched PubMed, PsychInfo, and Scopus for randomized controlled clinical trials assessing the efficacy of LCPUFA supplementation of infant formulas on cognition. Our analysis was restricted to randomized controlled clinical trials that examined the effect of LCPUFA supplementation on infant cognition using Bayley Scales of Infant Development. Our primary outcome was the weighted mean difference in Bayley Scales of Infant Development score between infants fed formula supplemented with LCPUFA compared with unsupplemented formula. We conducted secondary subgroup analyses and meta-regression to examine the effects of study sample, LCPUFA dose, and trial methodologic quality on measured efficacy of supplementation.


RESULTS
Twelve trials involving 1802 infants met our inclusion criteria. Our meta-analysis demonstrated no significant effect of LCPUFA supplementation of formula on infant cognition. There was no significant heterogeneity or publication bias between trials. Secondary analysis failed to show any significant effect of LCPUFA dosing or prematurity status on supplementation efficacy.


CONCLUSIONS
LCPUFA supplementation of infant formulas failed to show any significant effect on improving early infant cognition. Further research is needed to determine if LCPUFA supplementation of infant formula has benefits for later cognitive development or other measures of neurodevelopment.
Yale Child Study Center, Yale University, New Haven, Connecticut 06520, USA.
Ahmad
A
Qawasmi
Angeli
A
Landeros-Weisenberger
James F
JF
Leckman
Michael H
MH
Bloch
D003071:Cognition / Q000187:drug effects* / Q000502:physiology; D019587:Dietary Supplements; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D018730:Infant Behavior / Q000187:drug effects / Q000502:physiology / Q000523:psychology; D041943:Infant Formula / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic / Q000379:methods
D005231:Fatty Acids, Unsaturated